Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ETNB will rise by +10.60% over the next 2 Weeks and hit $16.41 by Wednesday, November 12, 2025. In that time frame, ETNB's share price is expected to range between $14.09 and $18.78.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Nov 12, 2025 | 15.14 | 17.38 | 19.93 |
| Nov 11, 2025 | 15.19 | 17.37 | 19.77 |
| Nov 10, 2025 | 15.19 | 17.36 | 19.61 |
| Nov 7, 2025 | 15.05 | 17.39 | 19.72 |
| Nov 6, 2025 | 15.14 | 17.50 | 19.81 |
| Nov 5, 2025 | 14.52 | 16.66 | 19.13 |
| Nov 4, 2025 | 14.50 | 16.66 | 18.92 |
| Nov 3, 2025 | 14.17 | 16.65 | 18.92 |
| Oct 31, 2025 | 14.33 | 16.68 | 19.10 |
| Oct 30, 2025 | 14.38 | 16.79 | 19.21 |
ETNB shares remained flat 0 in Thursday, October 30, 2025's trading session, starting and closing at a previous close of $14.84 to move at $14.84. The stock demonstrated notable intraday movement (see ETNB's key stats for a full breakdown), fluctuating between $14.84 and $14.84, a 0 trading range. While recent weeks have seen some volatility, ETNB has managed to secure a +0.47% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 55.47M shares changing hands, 47.39M more than the previous session. This amounted to $823.19M in total market activity.
Will ETNB Continue Its Upward Trend?
According to analyst ratings and projections for ETNB, 89bio, Inc. shares are anticipated to increase by +25.52%, potentially reaching $19.93 per share by November 12, 2025. Short-term technical indicators currently suggest a neutral sentiment for ETNB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the ETNB stock forecast, now is a good time to buy ETNB stock because its current trading price is -14.60% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ETNB covering social and institutional perspectives.
ETNB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ETNB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 74.11% to 77.88%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.62%, suggests strong medium-term momentum. However, the 100-day RSI, at 58.50%, maintains a neutral outlook for the long term. Insights into ETNB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
89bio Short-Term Forecasts
ETNB Forecast For Next 5 Days
Our algorithm anticipates 89bio (ETNB) stock could hit $16.19 by Nov 21, 2025. This represents a +9.09% rise from today's price, following a +0.27% change over the past five days.
ETNB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for 89bio, Inc. (ETNB) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $15.50, which would mean a +4.45% increase from the current price of $14.84. Projections for this period range from a high of $18.45 to a low of $12.70.
ETNB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for 89bio's price over the next three months point to a rise. ETNB stock is expected to peak at $38.02 on Mar 20, 2026 before potentially dipping to $23.11 on Apr 10, 2026. On average, ETNB is likely to trade around $31.36 in the coming 90 days.
89bio Stock Forecast 2025
Based on our predictive models, 89bio (ETNB) is expected to trade between $22.31 and $60.96 throughout 2026. This would result in an average price of $32.59, potentially offering investors a +119.61% return from current levels.
89bio, Inc. Monthly Forecast 2025–2026
November 2025
According to our latest forecast models, 89bio, Inc. (ETNB) is positioned to show a strong performance in November 2025. The price is predicted to move between $26.72 and $28.06, settling at an average of $27.31. This could translate to a +84.03% gain.
December 2025
Based on current market signals, 89bio, Inc. is projected to trend december 2025. We forecast a trading range from $27.55 to $36.31, with a likely average price of $32.31. Investors could expect a potential return of +117.72%.
January 2026
Our predictive algorithms indicate 89bio, Inc. stock may see a shift in January 2026. The expected range spans $26.41–$34.70, with an average target of $29.46. This represents a positive outlook and a possible gain of +98.52%.
February 2026
Analyzing established trends, 89bio, Inc. looks set to move in February 2026. Projections place the stock between $27.44 and $37.11, averaging around $32.44. This suggests a +118.60% gain from current levels.
March 2026
Market indicators suggest 89bio, Inc. could experience notable changes during March 2026. Prices could fluctuate within $28.43 to $38.02, with a midpoint forecast of $34.20. The stock might deliver a +130.46% gain.
April 2026
Forecasting for April 2026, models estimate that 89bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $22.31 and $32.64, averaging $26.36. This signals a positive trajectory with potential returns around +77.63%.
May 2026
According to our latest forecast models, 89bio, Inc. (ETNB) is positioned to show a strong performance in May 2026. The price is predicted to move between $27.42 and $36.50, settling at an average of $30.37. This could translate to a +104.65% gain.
June 2026
Based on current market signals, 89bio, Inc. is projected to trend june 2026. We forecast a trading range from $24.05 to $36.11, with a likely average price of $28.82. Investors could expect a potential return of +94.20%.
July 2026
Our predictive algorithms indicate 89bio, Inc. stock may see a shift in July 2026. The expected range spans $24.44–$43.14, with an average target of $31.31. This represents a positive outlook and a possible gain of +110.98%.
August 2026
Analyzing established trends, 89bio, Inc. looks set to move in August 2026. Projections place the stock between $29.87 and $47.81, averaging around $35.21. This suggests a +137.26% gain from current levels.
September 2026
Market indicators suggest 89bio, Inc. could experience notable changes during September 2026. Prices could fluctuate within $28.31 to $57.05, with a midpoint forecast of $36.64. The stock might deliver a +146.90% gain.
October 2026
Forecasting for October 2026, models estimate that 89bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $35.90 and $60.96, averaging $41.57. This signals a positive trajectory with potential returns around +180.12%.
ETNB's history of dividends and stock splits also plays a role in long-term investor confidence.